Evans, Elizabeth E <br/><br/>
Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.  [electronic resource] 

 -  Cancer immunology research  Jun 2015 
 - 689-701 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-6074 
<br/><br/><label>Standard No.: </label>10.1158/2326-6066.CIR-14-0171  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Blocking--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antigen-Presenting Cells--immunology<br/>Antigens, CD--immunology<br/>Antineoplastic Agents--pharmacology<br/>Breast Neoplasms--immunology<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cyclophosphamide--pharmacology<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Drug Synergism<br/>Female<br/>Humans<br/>Immunologic Memory<br/>Immunomodulation--drug effects<br/>Immunotherapy<br/>Lymphocyte Subsets--drug effects<br/>Lymphocytes, Tumor-Infiltrating--drug effects<br/>Mice<br/>Neoplasms--immunology<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Receptor, ErbB-2--metabolism<br/>Semaphorins--antagonists & inhibitors<br/>Tumor Burden--immunology<br/>Tumor Microenvironment--drug effects<br/>Xenograft Model Antitumor Assays